Streptomyces griseus: Difference between revisions
mNo edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==''Streptomyces griseus''== | |||
===Background=== | ===Background=== | ||
<em>Streptomyces griseus</em> is the producer of streptomycin, the first remedy for tuberculosis. Its first complete genome sequence was reported in 2008<sup>1</sup>. <em>S. griseus</em/> is also known for its production of an extracellular signalling molecule, A-factor, which turns on both morphological development and secondary metabolite production including streptomycin. | <em>Streptomyces griseus</em> is the producer of streptomycin, the first remedy for tuberculosis. Its first complete genome sequence was reported in 2008<sup>1</sup>. <em>S. griseus</em/> is also known for its production of an extracellular signalling molecule, A-factor, which turns on both morphological development and secondary metabolite production including streptomycin. | ||
===Growth & Maintenance=== | ===Growth & Maintenance=== | ||
| Line 22: | Line 18: | ||
===Links=== | ===Links=== | ||
===Genomes=== | |||
===Transcriptomes=== | |||
===Proteomics=== | |||
===Protocols=== | |||
<em>Escherichia coli</em> IR539 can be used to prepare plasmids mimicking the methylation profile of <em>Streptomyces griseus</em> to improve the transformation efficiency<sup>2</sup>. | <em>Escherichia coli</em> IR539 can be used to prepare plasmids mimicking the methylation profile of <em>Streptomyces griseus</em> to improve the transformation efficiency<sup>2</sup>. | ||
===Availability=== | |||
===Culture Collections=== | |||
===References=== | |||
<sup>1</sup>Ohnishi Y, <em>et al</em>. 2008. Genome Sequence of the Streptomycin-Producing Microorganism <em>Streptomyces griseus</em> IFO 13350. J. Bacteriol. 190: 4050-4060. | |||
<sup>2</sup>Suzuki <em>et al</em>. 2011. Improvement of transformation efficiency by strategic circumvention of restriction barriers in <em>Streptomyces griseus</em>. J. Microbiol. Biotechnol. 21: 675-678. | <sup>2</sup>Suzuki <em>et al</em>. 2011. Improvement of transformation efficiency by strategic circumvention of restriction barriers in <em>Streptomyces griseus</em>. J. Microbiol. Biotechnol. 21: 675-678. | ||
Revision as of 20:56, 4 October 2019
Streptomyces griseus
Background
Streptomyces griseus is the producer of streptomycin, the first remedy for tuberculosis. Its first complete genome sequence was reported in 20081. S. griseus is also known for its production of an extracellular signalling molecule, A-factor, which turns on both morphological development and secondary metabolite production including streptomycin.
Growth & Maintenance
S. griseus grows well on YMPD agar and liquid media.
Sporulation
S. griseus sporulates well on YMPD agar medium.
Strains
Streptomyces griseus IFO 13350
Links
Genomes
Transcriptomes
Proteomics
Protocols
Escherichia coli IR539 can be used to prepare plasmids mimicking the methylation profile of Streptomyces griseus to improve the transformation efficiency2.
Availability
Culture Collections
References
1Ohnishi Y, et al. 2008. Genome Sequence of the Streptomycin-Producing Microorganism Streptomyces griseus IFO 13350. J. Bacteriol. 190: 4050-4060.
2Suzuki et al. 2011. Improvement of transformation efficiency by strategic circumvention of restriction barriers in Streptomyces griseus. J. Microbiol. Biotechnol. 21: 675-678.
